J Cell Mol Med. 2024 Mar;28(6):e18078. doi: 10.1111/jcmm.18078. Epub 2023 Dec 10.
Yingxiao Cao, Xin Li, Shiqi Kong, Shuling Shang, Yanhui Qi. CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells. J Cell Mol Med. 2020; 24: 5135-5145. https://doi.org/10.1111/jcmm.15156. The above article, published online on 11 April 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor-in-Chief, Stefan Constantinescu, The Foundation for Cellular and Molecular Medicine, and John Wiley and Sons Ltd. The retraction has been agreed upon following an investigation into concerns raised by a third party, which revealed inappropriate duplications of images between this and other articles that were either previously published or published later in the same year in a different scientific context. Thus, the editors consider the conclusions of this manuscript substantially compromised.
曹迎晓、李鑫、孔诗琪、尚淑玲、齐艳辉。CDK4/6抑制可抑制胶质瘤细胞的肿瘤生长并增强替莫唑胺的疗效。《细胞与分子医学杂志》。2020年;24: 5135 - 5145。https://doi.org/10.1111/jcmm.15156。上述文章于2020年4月11日在线发表于威利在线图书馆(wileyonlinelibrary.com),已根据作者、期刊主编斯特凡·康斯坦丁内斯库、细胞与分子医学基金会以及约翰·威利父子有限公司之间的协议撤回。此次撤稿是在对第三方提出的担忧进行调查后达成的,调查发现本文与之前发表或同年晚些时候在不同科学背景下发表的其他文章之间存在不适当的图像重复。因此,编辑们认为该手稿得出的结论受到了严重影响。